Multiple Sclerosis Clinical Trial Results

Browse clinical trials for Multiple Sclerosis by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects
  Phase 3 · Mapi Pharma Ltd. · Completed · Aug 5, 2026
• A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Dis
  Phase 3 · Genzyme, a Sanofi Company · Terminated · Jul 12, 2022
• A Study of Oxidative Pathways in MS Fatigue
  Phase 2 · University of California, San Francisco · Completed · Feb 18, 2020
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults W
  Phase 3 · Hoffmann-La Roche · Active, not recruiting · Feb 17, 2026
• Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sc
  Phase 4 · Gregory Wu · Completed · Jul 28, 2026
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults W
  Phase 3 · Hoffmann-La Roche · Active, not recruiting · Jul 24, 2026
• Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
  Phase 3 · Shionogi · Completed · Aug 28, 2024
• Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis
  N/A · University of Alabama at Birmingham · Completed · Jul 20, 2026
• A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescen
  Phase 3 · Hoffmann-La Roche · Active, not recruiting · Jul 15, 2026
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
  Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID) · Terminated · Aug 22, 2025
• Low Load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis
  N/A · University of Colorado, Denver · Completed · Jun 9, 2026
• Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis
  Phase 1 · Cellerys AG · Completed · Jun 8, 2026
• Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
  Phase 3 · Novartis Pharmaceuticals · Active, not recruiting · Sep 19, 2018
• Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
  Phase 1 · Motric Bio · Completed · Jun 5, 2026
• Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
  Phase 2/3 · Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC · Terminated · May 27, 2026

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials